Adcetris 50 MG vial 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTJS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,048
Award facts
- Contract value 100% obligated
- $27,047.91 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,047.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. This firm fixed-price delivery order, issued without set-aside designation, was awarded on December 30, 2025, with an ultimate completion date of the same date. The product will be delivered to Park Ridge, Illinois, and represents a discrete fulfillment under DMS Pharmaceutical Group's broader pharmaceutical supply arrangement with the federal government.
This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy under which DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (designated SPE2DR) valued at $499,999,999 through December 31, 2036. The PPV-G GEN V contract positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of branded and generic pharmaceuticals, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group's selection reflects its demonstrated capability to fulfill diverse pharmaceutical requirements for military medical facilities and its established performance as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBTJS?
SPE2DR26FBTJS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FBTJS worth?
The government has obligated $27,048 on SPE2DR26FBTJS.
Is contract SPE2DR26FBTJS an order under another contract?
Yes. SPE2DR26FBTJS is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTJS competed?
The extent of competition for SPE2DR26FBTJS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award